2017
DOI: 10.3390/molecules22050782
|View full text |Cite
|
Sign up to set email alerts
|

Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications

Abstract: Nucleic acids, including DNA, microRNA (miRNA), small interfering RNA (siRNA), and antisense oligonucleotide (ASO), are powerful gene regulators, which have been demonstrated as promising drug candidates for therapeutic treatments. Nevertheless, poor cellular membrane permeability and serum stability have greatly hindered the applications of nucleic acids in biomedicine. To address these issues, associate carriers that can encapsulate and protect nucleic acids are urgently required. Mesoporous silica nanoparti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
48
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(48 citation statements)
references
References 87 publications
0
48
0
Order By: Relevance
“…Therefore, in an attempt to make a clinically relevant formulation and to test if the delivery agent influences the functionality of RNA fibers, we chose mesoporous silica‐based nanoparticles (MSNs) as an alternative non‐lipid carrier. MSNs have demonstrated tremendous potential for delivering active pharmaceuticals and TNAs targeting numerous diseases. Versatility of this delivery platform relies on MSNs' high surface area, tunable surface chemistry, biocompatibility, and well‐defined structure of pores.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, in an attempt to make a clinically relevant formulation and to test if the delivery agent influences the functionality of RNA fibers, we chose mesoporous silica‐based nanoparticles (MSNs) as an alternative non‐lipid carrier. MSNs have demonstrated tremendous potential for delivering active pharmaceuticals and TNAs targeting numerous diseases. Versatility of this delivery platform relies on MSNs' high surface area, tunable surface chemistry, biocompatibility, and well‐defined structure of pores.…”
Section: Resultsmentioning
confidence: 99%
“…MCM-41 mesoporous silica has an ordered hexagonal pore array of unidirectional and non-interconnecting pores, with diameters of 2-4 nm [33]. The porosity of MCM-41 silica makes it an ideal candidate for the loading and encapsulation of organic molecules or macromolecules such as proteins, DNA, and RNA [34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…Its advantages of uniform and tunable pore size, easy independent functionalization of the surface, internal and external pores and the gating mechanism of the pore opening make it a distinctive and promising drug carrier. Scientists have successfully worked on the utilization of these carriers for loading variety of cargo ranging from drugs to macromolecules such as proteins [ 23 , 24 ], DNA [ 25 , 26 ] and RNA [ 27 , 28 ]. An exhaustive set of literatures are available and research is still underway in evaluating new avenues for the use of MSNs in drug delivery.…”
Section: Introductionmentioning
confidence: 99%